There’s No Need To Panic Or Freeze When It Comes To Editas Medicine Inc (NASDAQ: EDIT)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Editas Medicine to Participate in Upcoming Investor Conferences.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $7.21 and fluctuated between $7.28 as its day high and $6.92 as its day low. The current market capitalization of Editas Medicine Inc is $588.84M. A total of 1.62 million shares were traded on the day, compared to an average of 1.83M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, EDIT has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 834 shares. Over the last 12 months, there were 6 BUYs and 17 SELLs from insiders. Insiders purchased 239,267 shares during that period but sold 25,455.

In the most recent transaction, Eaton Bruce sold 103 shares of EDIT for 10.90 per share on Dec 05. After the transaction, the EVP, CBO AND CTO now owns 74,791 company shares. In a previous transaction on Nov 14, Eaton Bruce sold 695 shares at 8.21 per share. EDIT shares that EVP, CBO AND CTO owns now total 74,894.

Among the insiders who sold shares, Eaton Bruce disposed of 139 shares on Nov 07 at a per-share price of $8.40. This resulted in the EVP, CBO AND CTO holding 75,589 shares of EDIT after the transaction. In another insider transaction, Eaton Bruce sold 103 shares at $8.82 per share on Sep 06. Company shares held by the EVP, CBO AND CTO now total 75,728.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for EDIT in the last 3 months, the mean price target is $14.87 with high estimates of $27.00 and low estimates of $7.00. In terms of 52-week highs and lows, EDIT has a high of $11.91 and a low of $6.08.

As of this writing, EDIT has an earnings estimate of $EDUT per share for the current quarter. EPS was calculated based on a consensus of Editas Medicine, Inc. estimates, with a high estimate of $FINDIT INC per share and a lower estimate of $SPDR S&P Emerging Markets Divid.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. EDIT’s latest balance sheet shows that the firm has $499.85M in Cash & Short Term Investments as of fiscal 2021. There were $26.38M in debt and $46.88M in liabilities at the time. Its Book Value Per Share was $4.41, while its Total Shareholder’s Equity was $553.64M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EDIT is Buy with a score of 3.88.

Most Popular

Related Posts